Orbia Advance Corporation, S.A.B. de C.V. (MXCHF)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	859	1,009	1,456	1,546	782	875
Cash & Short-Term Investments	859	1,009	1,456	1,546	782	875
Cash Growth	7.78%	-30.70%	-5.82%	97.70%	-10.63%	49.21%
Accounts Receivable	1,467	1,082	1,100	1,231	1,371	1,099
Other Receivables	381	366	363	430	225	231
Receivables	1,848	1,448	1,463	1,661	1,596	1,330
Inventory	1,217	1,098	1,200	1,320	1,292	861
Other Current Assets	133	55	51	57	54	90
Total Current Assets	4,057	3,610	4,170	4,584	3,724	3,156
Property, Plant & Equipment	3,796	3,702	3,839	3,528	3,397	3,509
Long-Term Investments	81	76	75	58	40	39
Goodwill	1,437	1,431	1,447	1,478	1,514	1,491
Other Intangible Assets	1,612	1,597	1,702	1,627	1,617	1,734
Long-Term Deferred Tax Assets	490	499	174	197	174	200
Other Long-Term Assets	131	142	145	152	121	82
Total Assets	11,608	11,057	11,552	11,624	10,587	10,211
Accounts Payable	970	821	848	813	1,047	789
Accrued Expenses	348	165	194	234	226	160
Short-Term Debt	-	99	-	-	115	40
Current Portion of Long-Term Debt	746	844	847	1,227	584	993
Current Portion of Leases	133	111	106	84	86	82
Other Current Liabilities	432	588	542	687	585	523
Total Current Liabilities	2,629	2,628	2,537	3,045	2,643	2,587
Long-Term Debt	4,550	4,078	4,420	3,936	3,280	3,131
Long-Term Leases	366	346	383	285	281	263
Long-Term Deferred Tax Liabilities	378	344	359	373	318	314
Other Long-Term Liabilities	577	243	129	150	124	188
Total Liabilities	8,646	7,769	7,967	7,926	6,867	6,757
Common Stock	256	256	256	256	256	256
Additional Paid-In Capital	1,475	1,475	1,475	1,475	1,475	1,475
Retained Earnings	1,200	438	604	881	966	1,108
Comprehensive Income & Other	-502	264	279	56	39	-346
Total Common Equity	2,429	2,433	2,614	2,668	2,736	2,493
Minority Interest	533	855	971	1,030	984	961
Shareholders' Equity	2,962	3,288	3,585	3,698	3,720	3,454
Total Liabilities & Equity	11,608	11,057	11,552	11,624	10,587	10,211
Total Debt	5,795	5,478	5,756	5,532	4,346	4,509
Net Cash (Debt)	-4,936	-4,469	-4,300	-3,986	-3,564	-3,634
Net Cash Per Share	-2.60	-2.34	-2.25	-2.08	-1.79	-1.79
Filing Date Shares Outstanding	1,914	1,906	1,907	1,906	1,953	2,017
Total Common Shares Outstanding	1,914	1,906	1,907	1,906	1,953	2,017
Working Capital	1,428	982	1,633	1,539	1,081	569
Book Value Per Share	1.27	1.28	1.37	1.40	1.40	1.24
Tangible Book Value	-620	-595	-535	-437	-395	-732
Tangible Book Value Per Share	-0.32	-0.31	-0.28	-0.23	-0.20	-0.36
Land	-	313	212	204	203	213
Buildings	-	1,134	1,138	1,069	1,002	1,006
Machinery	-	6,594	6,604	6,291	6,234	6,265
Construction In Progress	-	446	572	366	215	175

Source: S&P Global Market Intelligence. Standard template. Financial Sources.